Introduction
Whole blood (WB) transfusion remains a critical strategy in emergency medicine, particularly for patients with severe hemorrhage. Clinical guidelines support the use of both stored whole blood (SWB) and fresh whole blood (FWB), covering aspects such as definitions, indications, collection, storage, testing, and donor safety. WB transfusion is especially valuable in trauma care, military medicine, and resource-limited environments where rapid resuscitation is required.
Definitions and Types of Whole Blood
Stored Whole Blood (SWB)
Stored whole blood is collected in anticoagulant solutions such as CPD, CP2D, or CPDA-1. It is tested for transfusion-transmitted diseases and can be safely stored under refrigeration:
- Up to 21 days with CPD or CP2D
- Up to 35 days with CPDA-1
SWB maintains acceptable clotting function during storage, although its hemostatic efficiency may decline after the first two weeks. In such cases, supplementation with fresher blood or platelets may be required.
Fresh Whole Blood (FWB)
Fresh whole blood is collected in emergency situations from a walking blood bank (WBB). It:
- Is used within 24 hours (or up to 72 hours in some cases)
- Retains full hemostatic function
- Is not fully tested before transfusion
Because of the increased risk of infection, FWB is reserved for life-threatening situations when standard blood products are unavailable.
Compatibility and Safety Considerations
The most critical factor in WB transfusion is ABO compatibility to prevent hemolytic reactions:
- Group-specific transfusion is the safest approach
- Low-titer group O whole blood (LTOWB) can be used as a universal option
LTOWB contains low levels of anti-A and anti-B antibodies, reducing the risk of hemolysis. It has been widely used in military settings and is now considered a preferred option in emergency transfusion protocols.
Additional safety measures include:
- Screening donors for infectious diseases
- Avoiding Rh incompatibility in women of childbearing age
- Selecting donors with low risk of transfusion-related complications
Clinical Indications for Whole Blood
Whole blood is primarily indicated for:
- Massive hemorrhage
- Traumatic shock
- Emergency resuscitation
It is especially recommended in pre-hospital care and battlefield settings where rapid intervention is essential. However, WB should not be used for isolated deficiencies such as anemia without bleeding.
Historical Background
Blood transfusion has evolved significantly:
- First animal transfusion: 1665
- First human transfusion: 1818
- Discovery of ABO blood groups: early 1900s
- Rh factor identification: 1940
Whole blood has been widely used in military conflicts since World War I and remains essential in trauma care worldwide.
Whole Blood vs Component Therapy
Modern transfusion practice often uses separated components:
- Red blood cells (RBCs)
- Plasma
- Platelets
However, WB offers several advantages:
- Provides all components in a physiological ratio
- Requires less processing and storage complexity
- Delivers higher hematocrit and platelet levels
- Maintains better coagulation factor activity
Component therapy (1:1:1 ratio) approximates WB but results in diluted blood compared to natural WB composition.
Advantages of Whole Blood Transfusion
Whole blood provides key clinical and logistical benefits:
- Faster and more efficient resuscitation
- Reduced need for multiple transfusion products
- Simplified storage (single refrigeration system)
- Better availability in austere environments
FWB also avoids storage-related changes in red blood cells, known as the storage lesion, which may affect oxygen delivery.
Risks and Limitations
Despite its advantages, WB transfusion carries risks:
- Transmission of infections (especially with FWB)
- Clerical errors in emergency situations
- Potential hemolytic reactions
- Iron depletion in frequent donors
FWB should only be used when no safer alternatives are available and under strict medical supervision.
Walking Blood Bank (WBB) Programs
A WBB system allows rapid collection of blood from pre-screened donors in emergencies. Key elements include:
- Donor screening and identification
- Blood group verification
- Rapid infectious disease testing
- Proper documentation and traceability
Donors should ideally be low-titer group O and regularly monitored to prevent iron deficiency.
Recommendations for Clinical Practice
- SWB (especially LTOWB) is the preferred option for severe bleeding
- Use FWB only when SWB or components are unavailable
- Component therapy remains an acceptable alternative when WB is not accessible
- Early transfusion with balanced blood components improves outcomes in trauma
Conclusion
Whole blood transfusion is a powerful and efficient strategy for managing severe hemorrhage. With advantages in hemostasis, logistics, and rapid availability, it plays a key role in both civilian and military medicine. While stored whole blood is preferred due to safety, fresh whole blood remains a vital option in emergency scenarios. Ongoing research continues to refine its use, improve safety, and expand its applications in modern healthcare.